Xenotransplantation and immune response
Xenotransplantation and immune response is a research topic within Surgery. Science Explorer counts 9.9k research works in it since 1950. 19.5% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on xenotransplantation, particularly the use of pigs as organ donors for human transplantation. It covers topics such as genetic modification of pigs, porcine endogenous retroviruses, immunological barriers, xenograft rejection, and the potential applications in clinical xenotransplantation and biomedical research.
- Xenotransplantation
- Pig-to-Human Transplantation
- Genetic Modification of Pigs
- Porcine Endogenous Retroviruses
- Immunological Barriers
- Xenograft Rejection
- Transgenic Pigs
- Clinical Xenotransplantation
- Graft Survival
- Biomedical Research
- Research works
- 9.9k fractional, since 1950
- In the world top 10%
- 1.9k per year above
- Top-10% rate
- 19.5% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- -8% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Xenotransplantation and immune response research?
By volume, the United States and China publish the most (328 and 98 works in 2022–2025).
By volume, 2022–2025
- 1 United States 328 works
- 2 China 98 works
- 3 Germany 66 works
- 4 South Korea 49 works
- 5 Japan 35 works
- 6 India 33 works
- 7 United Kingdom 29 works
- 8 Brazil 26 works
- 9 France 24 works
- 10 Canada 22 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Xenotransplantation and immune response research?
By volume in 2022–2025, Massachusetts General Hospital publishes the most Xenotransplantation and immune response research, followed by University of Maryland, Baltimore and Harvard University.
By volume, 2022–2025
- 1 Massachusetts General HospitalUnited States 19 works
- 2 University of Maryland, BaltimoreUnited States 18 works
- 3 Harvard UniversityUnited States 12 works
- 4 Freie Universität BerlinGermany 10 works
- 5 University of Alabama at BirminghamUnited States 10 works
- 6 Ludwig-Maximilians-Universität MünchenGermany 9 works
- 7 Miami Transplant InstituteUnited States 8 works
- 8 Sungkyunkwan UniversitySouth Korea 8 works
- 9 Medizinische Hochschule HannoverGermany 7 works
- 10 Duke UniversityUnited States 6 works
Who are the leading researchers in Xenotransplantation and immune response?
The most-cited researchers publishing on Xenotransplantation and immune response include Harvey I. Pass and Thomas E. Starzl.
- 1 Harvey I. Pass United States 2.2k citations
- 2 Thomas E. Starzl United States 1.9k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Xenotransplantation and immune response research done?
The largest centres of Xenotransplantation and immune response research in 2022–2025 are Baltimore (United States), Boston (United States), Seoul (South Korea) and New York (United States). Among places with at least 20 works in it, it is an unusually large share of all research in Baltimore, Boston and New York.
Largest cities, 2022–2025
- 1 Baltimore United States 28 works
- 2 Boston United States 27 works
- 3 Seoul South Korea 25 works
- 4 New York United States 24 works
- 5 Munich Germany 18 works
- 6 Beijing China 16 works
- 7 Berlin Germany 14 works
- 8 Cambridge United States 13 works
- 9 Tokyo Japan 11 works
- 10 Birmingham United States 11 works
Where it is the local speciality
- BaltimoreUS · 27.8 works13×
- BostonUS · 26.7 works8.4×
- New YorkUS · 23.6 works3.9×
Location quotient: how much more of its research is in Xenotransplantation and immune response than the world average.
Where is the best place to study Xenotransplantation and immune response?
Among universities, judged by research, Harvard University, Freie Universität Berlin and University of Maryland, Baltimore score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Harvard UniversityUnited States | 49.1 | 48.8% | 10.7× | 12 | -35.3% |
| 2 | Freie Universität BerlinGermany | 38.8 | 40.2% | 29.5× | 10 | — |
| 3 | University of Maryland, BaltimoreUnited States | 34.9 | 18.9% | 63.5× | 18 | -9.7% |
| 4 | University of Alabama at BirminghamUnited States | 31.3 | 38.9% | 24.1× | 10 | — |
| 5 | Ludwig-Maximilians-Universität MünchenGermany | 11.6 | 19.7% | 15.9× | 9 | -34.9% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Xenotransplantation and immune response research growing?
Output in 2018–2022 was 8% lower than in 2013–2017, peaking in 1998.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.